Maturity‐Onset Diabetes of the Young (MODY) With HNF1B p.Glu105Lys Mutation Achieving Significant Insulin Reduction on Tirzepatide: A Case Report

ABSTRACT This report describes the first case of maturity‐onset diabetes in young (MODY) with HNF1B mutation started administration of the dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide. A 26‐year‐old female with a 15‐year history of diabe...

Description complète

Détails bibliographiques

Auteurs principaux:	Mihiro Sue, Mayu Watanabe, Ayumi Inoue, Akihiro Katayama, Sanae Teshigawara, Yuichi Matsushita, Masaya Takeda, Izumi Iseda, Jun Eguchi, Kazuyuki Hida
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2025-02-01
Collection:	Clinical Case Reports
Sujets:	glucagon‐like peptide‐1 (GLP‐1) glucose‐dependent insulinotropic polypeptide (GIP) maturity‐onset diabetes in young (MODY) tirzepatide
Accès en ligne:	https://doi.org/10.1002/ccr3.70173
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!